Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P N Durrington

Showing results (51-60 of 189) with videos related to

Pageof 19
Sort By:
Clinical Biochemistry|October 1, 1992
Postprandial plasma lipoprotein responses to a mixed meal in subjects with hyperapobetalipoproteinaemiaD Bhatnagar, P N Durrington, S Arrol
Heart (British Cardiac Society)|May 24, 2006
American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectivelyP McElduff, M Jaefarnezhad, P N Durrington
QJM : Monthly Journal of the Association of Physicians|November 28, 2002
Preventing cardiovascular disease in hypertension: effects of lowering blood pressure and cholesterolR Green, S Kwok, P N Durrington
Biochemical and Biophysical Research Communications|June 27, 1998
Lack of protection against oxidative modification of LDL by avian HDLB Mackness, P N Durrington, M I Mackness
Journal of Cardiovascular Pharmacology|January 1, 1990
Bezafibrate retard in patients with insulin-dependent diabetes: effect on serum lipoproteins, fibrinogen, and glycemic controlP N Durrington, P H Winocour, D Bhatnagar
Lancet (London, England)|August 18, 2004
Paraoxonase polymorphisms and coronary heart diseaseP N Durrington, B Mackness, M I Mackness
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 2, 1978
Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinaemiaP N Durrington, C H Bolton, M Hartog
Metabolism: Clinical and Experimental|March 1, 1988
Hypertriglyceridemia and hyperuricemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trialM D Bastow, P N Durrington, M Ishola
Biochemical Society Transactions|August 1, 1991
Substrate specificity of human serum paraoxonaseM I Mackness, S Arrol, P N Durrington
Current Opinion in Lipidology|August 17, 2000
How high-density lipoprotein protects against the effects of lipid peroxidationM I Mackness, P N Durrington, B Mackness
Pageof 19

Showing results (51-60 of 189) with videos related to

Sort By:
Pageof 19
Clinical Biochemistry|October 1, 1992
Postprandial plasma lipoprotein responses to a mixed meal in subjects with hyperapobetalipoproteinaemiaD Bhatnagar, P N Durrington, S Arrol
Heart (British Cardiac Society)|May 24, 2006
American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectivelyP McElduff, M Jaefarnezhad, P N Durrington
QJM : Monthly Journal of the Association of Physicians|November 28, 2002
Preventing cardiovascular disease in hypertension: effects of lowering blood pressure and cholesterolR Green, S Kwok, P N Durrington
Biochemical and Biophysical Research Communications|June 27, 1998
Lack of protection against oxidative modification of LDL by avian HDLB Mackness, P N Durrington, M I Mackness
Journal of Cardiovascular Pharmacology|January 1, 1990
Bezafibrate retard in patients with insulin-dependent diabetes: effect on serum lipoproteins, fibrinogen, and glycemic controlP N Durrington, P H Winocour, D Bhatnagar
Lancet (London, England)|August 18, 2004
Paraoxonase polymorphisms and coronary heart diseaseP N Durrington, B Mackness, M I Mackness
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 2, 1978
Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinaemiaP N Durrington, C H Bolton, M Hartog
Metabolism: Clinical and Experimental|March 1, 1988
Hypertriglyceridemia and hyperuricemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trialM D Bastow, P N Durrington, M Ishola
Biochemical Society Transactions|August 1, 1991
Substrate specificity of human serum paraoxonaseM I Mackness, S Arrol, P N Durrington
Current Opinion in Lipidology|August 17, 2000
How high-density lipoprotein protects against the effects of lipid peroxidationM I Mackness, P N Durrington, B Mackness
Pageof 19